• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿霉素与葫芦素B在间变性甲状腺癌细胞中具有协同细胞毒性。

Doxorubicin has a synergistic cytotoxicity with cucurbitacin B in anaplastic thyroid carcinoma cells.

作者信息

Kim Si Hyoung, Kang Jun Goo, Kim Chul Sik, Ihm Sung-Hee, Choi Moon Gi, Yoo Hyung Joon, Lee Seong Jin

机构信息

1 Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Hallym University, Chuncheon, Republic of Korea.

2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang-Si, Republic of Korea.

出版信息

Tumour Biol. 2017 Feb;39(2):1010428317692252. doi: 10.1177/1010428317692252.

DOI:10.1177/1010428317692252
PMID:28218042
Abstract

In this study, the combined effect of doxorubicin with cucurbitacin B on survival of anaplastic thyroid carcinoma cells was evaluated. For experiments, 8505C and CAL62 human anaplastic thyroid carcinoma cells were used. Cell viability, the percentage of viable cells, and cytotoxic activity were measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, multiplexed cytotoxicity assay, and cytotoxicity assay, respectively. Reactive oxygen species production was measured. In experiments, doxorubicin and cucurbitacin B reduced cell viability in a dose- and time-dependent manner. Cotreatment of doxorubicin and cucurbitacin B, compared with treatment of doxorubicin alone, decreased the percentage of viable cells and increased cytotoxic activity. All of the combination index values were lower than 1.0, suggesting the synergism between doxorubicin and cucurbitacin B in induction of cytotoxicity. In cells treated with both doxorubicin and cucurbitacin B, compared with doxorubicin alone, the protein levels of cleaved poly(adenosine diphosphate-ribose) polymerase and cyclooxygenase 2 and reactive oxygen species production were enhanced. In contrast, the protein levels of B-cell chronic lymphocytic leukemia/lymphoma 2 and survivin and B-cell chronic lymphocytic leukemia/lymphoma 2/B-cell chronic lymphocytic leukemia/lymphoma 2-associated x protein ratio were diminished. The protein levels of Janus kinase 2 and signal transducer and activator of transcription 3 were reduced, while phospho-extracellular signal-regulated kinase 1/2 protein levels were elevated without change in total extracellular signal-regulated kinase 1/2 protein levels. These results suggest that doxorubicin synergizes with cucurbitacin B in induction of cytotoxicity in anaplastic thyroid carcinoma cells. Moreover, synergistic cytotoxicity of doxorubicin with cucurbitacin B is mediated by B-cell chronic lymphocytic leukemia/lymphoma 2 family proteins, survivin, and reactive oxygen species and modulated by Janus kinase 2/signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2 in anaplastic thyroid carcinoma cells.

摘要

在本研究中,评估了阿霉素与葫芦素B联合作用对间变性甲状腺癌细胞存活率的影响。实验采用8505C和CAL62人间变性甲状腺癌细胞。分别使用3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐法、多重细胞毒性测定法和细胞毒性测定法测量细胞活力、活细胞百分比和细胞毒性活性。检测了活性氧的产生。实验中,阿霉素和葫芦素B以剂量和时间依赖性方式降低细胞活力。与单独使用阿霉素相比,阿霉素与葫芦素B联合处理降低了活细胞百分比并增加了细胞毒性活性。所有联合指数值均低于1.0,表明阿霉素与葫芦素B在诱导细胞毒性方面具有协同作用。在同时用阿霉素和葫芦素B处理的细胞中,与单独使用阿霉素相比,裂解的聚(腺苷二磷酸核糖)聚合酶和环氧化酶2的蛋白水平以及活性氧的产生增加。相反,B细胞慢性淋巴细胞白血病/淋巴瘤2和存活素的蛋白水平以及B细胞慢性淋巴细胞白血病/淋巴瘤2/B细胞慢性淋巴细胞白血病/淋巴瘤2相关X蛋白比值降低。Janus激酶2和信号转导及转录激活因子3的蛋白水平降低,而磷酸化细胞外信号调节激酶1/2蛋白水平升高,细胞外信号调节激酶1/2总蛋白水平无变化。这些结果表明,阿霉素与葫芦素B在诱导间变性甲状腺癌细胞毒性方面具有协同作用。此外,阿霉素与葫芦素B的协同细胞毒性由B细胞慢性淋巴细胞白血病/淋巴瘤2家族蛋白、存活素和活性氧介导,并由Janus激酶2/信号转导及转录激活因子3和细胞外信号调节激酶1/2在间变性甲状腺癌细胞中调节。

相似文献

1
Doxorubicin has a synergistic cytotoxicity with cucurbitacin B in anaplastic thyroid carcinoma cells.阿霉素与葫芦素B在间变性甲状腺癌细胞中具有协同细胞毒性。
Tumour Biol. 2017 Feb;39(2):1010428317692252. doi: 10.1177/1010428317692252.
2
Cytotoxic effect of celastrol alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells.雷公藤红素单独或与紫杉醇联合对间变性甲状腺癌细胞的细胞毒性作用。
Tumour Biol. 2017 May;39(5):1010428317698369. doi: 10.1177/1010428317698369.
3
The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells.热休克蛋白90抑制剂SNX5422在诱导间变性甲状腺癌细胞死亡方面与组蛋白去乙酰化酶抑制剂具有协同活性。
Endocrine. 2016 Feb;51(2):274-82. doi: 10.1007/s12020-015-0706-7. Epub 2015 Jul 29.
4
The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells.二肽基肽酶-IV抑制剂吉格列汀单独使用或与NVP-AUY922联合使用时,对甲状腺癌细胞具有细胞毒性活性。
Tumour Biol. 2017 Oct;39(10):1010428317722068. doi: 10.1177/1010428317722068.
5
Novel heat shock protein 90 inhibitor NVP-AUY922 synergizes with the histone deacetylase inhibitor PXD101 in induction of death of anaplastic thyroid carcinoma cells.新型热休克蛋白90抑制剂NVP - AUY922与组蛋白去乙酰化酶抑制剂PXD101协同诱导间变性甲状腺癌细胞死亡。
J Clin Endocrinol Metab. 2015 Feb;100(2):E253-61. doi: 10.1210/jc.2014-3101. Epub 2014 Nov 12.
6
Suppression of AKT Potentiates Synergistic Cytotoxicity of Apigenin with TRAIL in Anaplastic Thyroid Carcinoma Cells.抑制AKT增强芹菜素与TRAIL在间变性甲状腺癌细胞中的协同细胞毒性。
Anticancer Res. 2015 Dec;35(12):6529-37.
7
Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.葫芦素 I 通过靶向信号转导子和转录激活子 3 通路降低甲状腺癌源性 CD133+细胞的自我更新和放化疗抵抗能力。
J Pharmacol Exp Ther. 2012 May;341(2):410-23. doi: 10.1124/jpet.111.188730. Epub 2012 Feb 10.
8
Synergy between isobavachalcone and doxorubicin suppressed the progression of anaplastic thyroid cancer through ferroptosis activation.异甘草素与阿霉素协同作用通过铁死亡激活抑制间变性甲状腺癌的进展。
Braz J Med Biol Res. 2024 Aug 19;57:e13679. doi: 10.1590/1414-431X2024e13679. eCollection 2024.
9
Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells.表小檗碱联合组蛋白去乙酰化酶抑制剂对甲状腺癌细胞具有协同细胞毒性。
Endocrine. 2019 Jul;65(1):110-120. doi: 10.1007/s12020-019-01885-1. Epub 2019 May 17.
10
Sulforaphene Enhances The Efficacy of Photodynamic Therapy In Anaplastic Thyroid Cancer Through Ras/RAF/MEK/ERK Pathway Suppression.萝卜硫素通过抑制Ras/RAF/MEK/ERK信号通路增强光动力疗法对间变性甲状腺癌的疗效。
J Photochem Photobiol B. 2018 Feb;179:46-53. doi: 10.1016/j.jphotobiol.2017.12.013. Epub 2017 Dec 11.

引用本文的文献

1
Antiinflammatory effects of cucurbitacins and sorafenib in Hepg2 cells by modulating the IκB/NF-κB/COX-2 pathway through Akt signaling.葫芦素和索拉非尼通过Akt信号通路调节IκB/NF-κB/COX-2途径对Hepg2细胞的抗炎作用。
Turk J Biol. 2025 Jan 15;49(3):309-323. doi: 10.55730/1300-0152.2747. eCollection 2025.
2
Recent Advances in the Application of Cucurbitacins as Anticancer Agents.葫芦素作为抗癌剂应用的最新进展
Metabolites. 2023 Oct 14;13(10):1081. doi: 10.3390/metabo13101081.
3
Combinatorial Therapies in Thyroid Cancer: An Overview of Preclinical and Clinical Progresses.
甲状腺癌的联合治疗:临床前和临床进展概述。
Cells. 2020 Mar 30;9(4):830. doi: 10.3390/cells9040830.
4
Therapeutic advances in anaplastic thyroid cancer: a current perspective.间变性甲状腺癌的治疗进展:现状与展望。
Mol Cancer. 2018 Oct 23;17(1):154. doi: 10.1186/s12943-018-0903-0.
5
Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells.二甲双胍,一种新型的二肽基肽酶-4 抑制剂,与组蛋白去乙酰化酶抑制剂 PXD101 在甲状腺癌细胞中具有协同细胞毒性作用。
J Endocrinol Invest. 2018 Jun;41(6):677-689. doi: 10.1007/s40618-017-0792-x. Epub 2017 Nov 16.